Sutter Health, UPMC, and DNAnexus Initiate Collaboration to Improve Personalized Treatments for People with Multiple Sclerosis

49

MOUNTAIN VIEW, Calif. & SACRAMENTO, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BioIT19?src=hash" target="_blank"gt;#BioIT19lt;/agt;–DNAnexus and the Sutter Health network announced the first large-scale clinico-genomic MS research study conducted by a leading healthcare system http://www.businesswire.com/news/home/20190415005212/en/Sutter-Health-UPMC-DNAnexus-Initiate-Collaboration-Improve/?feedref=JjAwJuNHiystnCoBq_hl-c_SXB-bY2T43rxUBWxEIvSqcp-o_pnudlUwsb5apQ1S4gUE65BTfjH3-pSuqdv0gW3cb3F4oTIgUqCPafFkgu61_izUl0FZkbDFZ7ZhSEmC